Literature DB >> 3540834

Experience with heart transplantation in children.

F J Fricker, B P Griffith, R L Hardesty, A Trento, L M Gold, K Schmeltz, L B Beerman, D R Fischer, R A Mathews, W H Neches.   

Abstract

Between March 1981 and March 1986, 200 orthotopic heart transplantations were performed at the University of Pittsburgh. Fourteen of those procedures were carried out in children 2 to 16 years of age. Two children received combined liver and heart transplants; one because of familial hypercholesterolemia with associated ischemic heart disease, and the other because of dilated cardiomyopathy associated with intrahepatic biliary atresia. Eight patients had dilated cardiomyopathy, and two had myocarditis. Two had heart transplantations for congenital heart disease: one had multiple muscular ventricular septal defects repaired in infancy and had an associated cardiomyopathy, and the other developed a cardiomyopathic ventricle from a congenital right coronary artery to right atrial fistula. Chronic immune suppression consisted 0.2 to 0.5 mg/kg/d of prednisone and 5 to 50 mg/kg/d cyclosporine, with the addition of antithymocyte globulin for unresolved moderate or severe acute rejection. There were three early postoperative deaths: one from intracranial bleeding, one from Pseudomonas mediastinitis, and one from ischemic injury to transplanted organs. Early postoperative complications included reversible renal failure, hypertension, and seizures. Late problems were related to allograft rejection and side effects of cyclosporine and corticosteroids. Significant rejection episodes occurred in all patients surviving longer than 2 weeks, with seven requiring antithymocyte globulin. Two patients died 8 months following transplantation of severe acute and chronic rejection; another patient required retransplantation for ischemic cardiomyopathy resulting from chronic rejection but subsequently died of recurring rejection 3 months after the second transplantation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3540834

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Early experience of heart-lung transplantation.

Authors:  R L Smyth; T W Higenbottam; J P Scott; J P McGoldrick; B Whitehead; P Helms; M de Leval; J Wallwork
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

Review 2.  Update on pediatric heart transplantation. Long-term complications.

Authors:  R J Gajarski; D L Kearney; J K Price; S W Denfield
Journal:  Tex Heart Inst J       Date:  1997

Review 3.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Progressive visual deterioration leading to blindness after pediatric heart transplantation.

Authors:  K O Schowengerdt; R J Gajarski; S Denfield
Journal:  Tex Heart Inst J       Date:  1993

5.  Effect of cardiac or heart-lung transplantation on the quality of life of the paediatric patient.

Authors:  J Wray; R Radley-Smith; M Yacoub
Journal:  Qual Life Res       Date:  1992-02       Impact factor: 4.147

6.  Cognitive function and behavioural status in paediatric heart and heart-lung transplant recipients: the Harefield experience.

Authors:  J Wray; C Pot-Mees; H Zeitlin; R Radley-Smith; M Yacoub
Journal:  BMJ       Date:  1994-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.